Hot line:010-61006450
ENAbout Us
Stock(600222)
Leadingpharm was founded in 2005.In 2015, Leadingpharm was reorganized and listed with Henan Tailong Pharmaceutical (Stock Code: 600222), aiming to promote the development of China's pharmaceutical industry with innovative modes of research, development and service, as well as information technology. Based on the international perspective, Leadingpharm has formed its core competitive advantages, which are internationalization, integration and industrialization. With the mature and perfect drug R & D management system, rich project experience and the team of thousands of senior experts at home and abroad, Leadingpharm has formed a CXO Service System covering the whole industry chain including preclinical research, clinical CRO, CDMO and MAH, and realized the full coverage of innovative drugs, high-end complex preparations, cell gene therapy drugs and other fields, which can provide real one-stop service for global customers.
Services
-
New Drug Screening
high-throughput drug screening, active compound discovery, target verification, lead compound optimization, preclinical drug candidate selection, etc
-
Drug Evaluation
drug discovery, chemical synthesis, biological analysis, PK/PD model fitting, macromolecular drugs, clinical declaration, toxicology, pharmacokinetics, etc
-
API and Preparation CMC
API synthesis process, formulation process , drug quality research and method verification, impurity customization, special substance testing, etc
-
Drug CDMO
Macromolecular Pilot and Large-scale Production Service Platform, Small Molecule Drug CDMO Platform, CDMO Platform of Cell Therapy Drugs
-
Manage Service
Projects Initiation； Drug Administration； Clinical Medical Services； Quality Management System.
-
Park Services
Enterprise Integrated Management Service, Declaration Services of Science and Technology Project, Public Technology Service and Information Platform Service
-
CRO Services
phase I~IV clinical trials of innovative drugs and generic drugs, BE trials of generic drugs, pharmacokinetics (PK/PD) clinical studies, etc
-
Import and Export Registration
introduction of characteristic varieties (agent registration and localized production), China-U.S. registration on API and Preparation, etc
- Shenyang
- Dalian
- Hangzhou
- Beijing
- Shijiazhuang
- Zhengzhou
- Wuhan
- Changsha
- Guangzhou
- Taiyuan
- Guizhou
- Xian
- Tianjin
-
Zhengzhou CXO Innovation Transformation Base
new drug screening and testing platform, animal platform, large small molecule pilot and production platform, cell technology platform
Contact number: 010-61006450
Address: Life Zhengzhou, Airport Economy Zone -
Beijing Research Institute
API Synthesis; Preparation Research and Development; Analysis and Detection; Project Approval; Registration; In Vivo and In Vitro Bridging
Contact number: 010-61006450
Address: Building 12, East District, No. 10 Dongbeiwangdong Road, Haidian, Beijing；Block B, Hexie Technology Building
-
Zhengzhou Marine
Clinical Research, Medical Program Design and Writing, Pharmacovigilance, Data Management and Statistics, Third-party Audit, SMO, IND
Contact number: 010-61006450
Address: Life Zhengzhou, Airport Economy Zone
-
Miyun Research Institute
Pilot Study of API, R&D of Special Preparations
Contact number: 010-61006450
Address: No. 8, Yunteng Road, Miyun Economic and Technological Development Zone, Beijing
News
- Company News
The Clinical Research Protocol Seminar of Insulin-promoting Secretory Peptide Fusion Protein Injection Launched by Beijing Leadingpharm · Deep Blue Ocean (Zhengzhou), CNBG and Lanzhou Institute of CNBG was Held Smoothly
Recently, the Clinical Research Protocol Seminar of Insulin-promoting Secretory Peptide Fusion Protein Injection launched by Beijing Leadingpharm · Deep Blue Ocean (Zhengzhou), CNBG and Lanzhou Institute of CNBG was held smoothly online.
Opportunities and Challenges Coexist. Promote CXO to Upgrade the Industry - Exclusive Interview with Wallace Tao, Chairman of Leadingpharm
This article is forwarded from Linkong Biomedical Park.
Alumni Exchange | Alumni of China Europe International Business School (CEIBS) Came to Leadingpharm and Decrypted the Pharmaceutical R & D Enterprise
On February 25, the first stop of the 2022 "Together with You" series of study tour activities initiated by the Alumni Relations Office of CEIBS Beijing Campus, "Decrypting Pharmaceutical R & D Enterprises - Entering Leadingpharm Pharmaceutical Technology", was successfully held in Beijing.
010-61006450
Address：
Marketing Department：
Leadingpharm
Pharm News
010-61006450
